Announcement PDF Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Announcement Summary Entity name PHARMAUST LIMITED Date of this announcement Friday June 28, 2024 The +securities the subject of this notification are: +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX Total number of +securities to be issued/transferred ASX +security code New class - code to be confirmed Security description Total number of +securities to be issued/transferred Issue date 5,000,000 28/06/2024 Unlisted Options Refer to next page for full details of the announcement Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 1/6 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Part 1 - Entity and announcement details 1.1 Name of entity PHARMAUST LIMITED We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities. 1.2 Registered number type Registration number ABN 35094006023 1.3 ASX issuer code PAA 1.4 The announcement is New announcement 1.5 Date of this announcement 28/6/2024 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 2/6 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Part 2 - Issue details 2.1 The +securities the subject of this notification are: +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX Previous Appendix 3B details: Announcement Date and Time Announcement Title Selected Appendix 3B to submit quotation request 21-Jun-2024 09:24 New - Proposed issue of securities PAA A placement or other type of issue 2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? Yes 2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B Issue of 4,657,895 Tranche 2 Placement Shares to certain Related Parties of the Company, including Directors, subject to shareholder approval, and the issue of Shares under the Share Purchase Plan (SPP). Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 3/6 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Part 3A - number and type of +securities the subject of this notification (existing class or new class) where issue has previously been notified to ASX in an Appendix 3B Placement Details ASX +security code and description new unquoted class of security Date the +securities the subject of this notification were issued 28/6/2024 Any other information the entity wishes to provide about the +securities the subject of this notification Issue of 5,000,000 unlisted PharmAust options to the Sole Lead Manager, expiring 28 June 2026, with an exercise price of $0.3325 (33.25 cents) per option, being a 75% premium to the issue price under the Placement. Issue details Number of +securities 5,000,000 Were the +securities issued for a cash consideration? No Please describe the consideration being provided for the +securities The Options are being issued as part consideration to the Lead Manager. Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 4/6 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Part 3C - number and type of +securities the subject of this notification (new class) ASX +security code +Security description New class - code to be confirmed Unlisted Options +Security type ISIN code Options Date the +securities the subject of this notification were issued 28/6/2024 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1? No Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued. https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02819683-6A1212474 Options Details +Security currency Exercise price Expiry date AUD - Australian Dollar AUD 0.33250000 28/6/2026 Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option PAA : ORDINARY FULLY PAID Any other information the entity wishes to provide about the +securities the subject of this notification Issue details Number of +securities 5,000,000 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 5/6 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Part 4 - +Securities on issue Following the issue, conversion or payment up of the +securities the subject of this notification, the +securities of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (Total number of each +class of +securities issued and quoted on ASX) ASX +security code and description Total number of +securities on issue PAA : ORDINARY FULLY PAID 443,872,733 PAAOA : OPTION EXPIRING 30-APR-2026 116,415,955 4.2 Unquoted +securities (Total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue PAAAO : OPTION EXPIRING 19-JAN-2026 EX $0.175 2,300,000 PAAAM : OPTION EXPIRING 28-FEB-2026 EX $0.10 2,047,500 PAAAG : PERFORMANCE RIGHTS 1,125,000 PAAAN : OPTION EXPIRING 31-DEC-2025 EX $0.15 3,000,000 New class - code to be confirmed : Unlisted Options 5,000,000 Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities 6/6